Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Natera Inc. Common Stock (NTRA) vs Stanley Black & Decker, Inc. (SWK) Price & Performance

Natera Inc. Common StockTrade
Stanley Black & Decker, Inc.Trade

Price performance (Past 24H)

Key statistics

Natera Inc. Common Stock vs Stanley Black & Decker, Inc. — how do they compare? Natera Inc. Common Stock trades at $394.6 (market cap $57.03B), while Stanley Black & Decker, Inc. trades at $90.48 (market cap $13.70B). The key difference: Natera Inc. Common Stock is far larger — about 4.2× Stanley Black & Decker, Inc.'s market cap, and Stanley Black & Decker, Inc. pays a 3.7% dividend while Natera Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Natera Inc. Common Stock for 0 Days and Stanley Black & Decker, Inc. for 62 Days on average.

NTRASWK
Market Cap
$57.03B$13.70B
Volume
1,131,1571,098,669
Sector
HealthIndustrials
52-Week High
$425.64$104.00
52-Week Low
$179.42$62.12
Typical Hold Time
0 Days62 Days
Enterprise Value
$56.18B$17.86B
Dividend Yield
—3.7%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Natera Inc. Common Stock

NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.

NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.

Stanley Black & Decker, Inc.

Stanley Black & Decker (SWK) trades at $90.29, up 1.85% today, with a bearish technical signal from moving averages despite recent earnings beats. The company shows improving profitability with a net income margin of 4.07% in 2025, and revenue is projected to grow to $15.2B in 2026. Recent news highlights product launches like the dustbuster mini and management's focus on margin gains and brand strength.

The outlook is cautiously optimistic with a consensus price target of $93.00, offering modest upside. Key risks include competitive pressures and execution challenges, but strong institutional buying and a dividend history support long-term value. Investors should weigh improving fundamentals against near-term technical weakness.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NTRA
100% Buy0% Sell
Avg holding period · 0 Days
SWK

No sentiment data available yet.

About Natera Inc. Common Stock

Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.

Read more on NTRA →

About Stanley Black & Decker, Inc.

Stanley Black & Decker Inc is a manufacturer of hand and power tools. The company operates three business segments: tools and storage, security, and industrial. Tools and storage, the largest segment by revenue, sells hand tools and power tools to professional end-users, distributors, retail consumers, and industrial customers. Security installs electronic security systems and provides electronic security services including alarm monitoring and video surveillance. Industrial sells engineered fastening products such as stud-welding systems, blind inserts and tools, and engineered plastic and mechanical fasteners. The largest end market is the United States of America.

Read more on SWK →